Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.

The declining efficacy of artemisinin derivatives against Plasmodium falciparum highlights the urgent need to identify alternative highly potent compounds for the treatment of malaria. In Papua Indonesia, where multidrug resistance has been documented against both P. falciparum and P. vivax malaria,...

Description complète

Détails bibliographiques
Auteurs principaux:	Marfurt, J, Chalfein, F, Prayoga, P, Wabiser, F, Wirjanata, G, Sebayang, B, Piera, K, Wittlin, S, Haynes, R, Möhrle, J, Anstey, N, Kenangalem, E, Price, R
Format:	Journal article
Langue:	English
Publié:	2012

Documents similaires

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
par: Marfurt, J, et autres
Publié: (2011)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
par: Price, R, et autres
Publié: (2010)

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
par: Marfurt, J, et autres
Publié: (2011)

Potent ex vivo activity of naphthoquine and methylene blue against drug-resistant clinical isolates of Plasmodium falciparum and Plasmodium vivax
par: Wirjanata, G, et autres
Publié: (2015)

Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
par: Wirjanata, G, et autres
Publié: (2015)

In vitro and molecular characterisation of multidrug resistant Plasmodium vivax.
par: Suwanarusk, R, et autres
Publié: (2008)

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.
par: Suwanarusk, R, et autres
Publié: (2008)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
par: Marfurt, J, et autres
Publié: (2021)

Plasmodium falciparum and P. vivax demonstrate contrasting chloroquine resistance reversal phenotypes
par: Wirjanata, G, et autres
Publié: (2017)

Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
par: Russell, B, et autres
Publié: (2008)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
par: Karyana, M, et autres
Publié: (2008)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
par: Poespoprodjo, JR, et autres
Publié: (2008)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
par: Phyo, A, et autres
Publié: (2016)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
par: Kho, S, et autres
Publié: (2016)

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
par: Salwati, E, et autres
Publié: (2011)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant <it>Plasmodium vivax </it>and <it>Plasmodium falciparum</it>
par: Okoseray Maurits J, et autres
Publié: (2008-08-01)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
par: Hasugian, A, et autres
Publié: (2007)

Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.
par: Wirjanata, G, et autres
Publié: (2015)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
par: Ratcliff, A, et autres
Publié: (2007)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
par: Kho, S, et autres
Publié: (2016)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
par: Poespoprodjo, JR, et autres
Publié: (2014)

Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.
par: Kho, S, et autres
Publié: (2015)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
par: Yeo, T, et autres
Publié: (2010)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
par: Karyana, M, et autres
Publié: (2007)

Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.
par: Woodberry, T, et autres
Publié: (2008)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
par: Jeanne Rini Poespoprodjo, et autres
Publié: (2014-01-01)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
par: Tjitra, E, et autres
Publié: (2007)

Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms
par: Wirjanata, G, et autres
Publié: (2016)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
par: Pava, Z, et autres
Publié: (2020)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
par: Suwanarusk, R, et autres
Publié: (2007)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
par: Tjitra, E, et autres
Publié: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
par: Tjitra, E, et autres
Publié: (2008)

Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencing
par: Auburn, S, et autres
Publié: (2013)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
par: Hasugian, A, et autres
Publié: (2009)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
par: Rossarin Suwanarusk, et autres
Publié: (2007-10-01)

New endoperoxides highly active in vivo and in vitro against artemisinin-resistant Plasmodium falciparum
par: Lis Lobo, et autres
Publié: (2018-04-01)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia.
par: Zuleima Pava, et autres
Publié: (2020-05-01)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life.
par: Burdam, F, et autres
Publié: (2016)

Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.
par: Price, R, et autres
Publié: (2012)

Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax
par: Price, R, et autres
Publié: (2012)